Physician profile
Michael D Chesen
NPI 1619076692
$1,481.22
in general payments reported to CMS, 2019-2025
11 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $177 · 2021: $68.62 · 2022: $40.62 · 2023: $204 · 2024: $243 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492 · Entertainment: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.09 |
| Entertainment | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $345.40 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $265.88 | 2019-2021 | |
| Glaukos Corporation | $174.03 | 2024 | Idose |
| Alcon Vision LLC | $154.18 | 2019-2021 | |
| Genentech USA, INC. | $136.56 | 2019 | |
| Shire North American Group INC | $123.61 | 2019 | |
| Optos, INC. | $100.00 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $78.55 | 2019-2022 | |
| Optovue, INC. | $74.08 | 2020 | |
| Carl Zeiss Meditec, INC. | $16.12 | 2020 | |
| Sight Sciences, INC. | $12.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chesen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.